» Articles » PMID: 32081875

Exploiting Horizontal Pleiotropy to Search for Causal Pathways Within a Mendelian Randomization Framework

Overview
Journal Nat Commun
Specialty Biology
Date 2020 Feb 22
PMID 32081875
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

In Mendelian randomization (MR) analysis, variants that exert horizontal pleiotropy are typically treated as a nuisance. However, they could be valuable in identifying alternative pathways to the traits under investigation. Here, we develop MR-TRYX, a framework that exploits horizontal pleiotropy to discover putative risk factors for disease. We begin by detecting outliers in a single exposure-outcome MR analysis, hypothesising they are due to horizontal pleiotropy. We search across hundreds of complete GWAS summary datasets to systematically identify other (candidate) traits that associate with the outliers. We develop a multi-trait pleiotropy model of the heterogeneity in the exposure-outcome analysis due to pathways through candidate traits. Through detailed investigation of several causal relationships, many pleiotropic pathways are uncovered with already established causal effects, validating the approach, but also alternative putative causal pathways. Adjustment for pleiotropic pathways reduces the heterogeneity across the analyses.

Citing Articles

Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study.

Ning L, Gao Z, Chen D, Han J, Xie G, Sun J BMC Cancer. 2025; 25(1):389.

PMID: 40038628 PMC: 11877886. DOI: 10.1186/s12885-025-13690-3.


The Causal Relationship Between Acne Vulgaris and BMI: A Mendelian Randomization Study.

Li Z, Qi W, Zang T, Zhang Z J Cosmet Dermatol. 2025; 24(3):e70092.

PMID: 40035224 PMC: 11877415. DOI: 10.1111/jocd.70092.


Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study.

Li Y, Lv X, Lin J, Li S, Lin G, Huang Z Open Med (Wars). 2025; 20(1):20251154.

PMID: 39989616 PMC: 11843165. DOI: 10.1515/med-2025-1154.


Associations of cathepsins with pulmonary arterial hypertension mediated by circulating metabolites: A Mendelian randomization study.

Yang S, Chen Q, Yang B Medicine (Baltimore). 2025; 104(4):e41405.

PMID: 39854747 PMC: 11771745. DOI: 10.1097/MD.0000000000041405.


A practical guide for nephrologist peer reviewers: understanding and appraising Mendelian randomization studies.

Qing J, Li Y, Soliman K, Cheungpasitporn W Ren Fail. 2025; 47(1):2445763.

PMID: 39806780 PMC: 11734392. DOI: 10.1080/0886022X.2024.2445763.


References
1.
Holmes M, Ala-Korpela M, Davey Smith G . Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. Nat Rev Cardiol. 2017; 14(10):577-590. PMC: 5600813. DOI: 10.1038/nrcardio.2017.78. View

2.
Davey Smith G, Hemani G . Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014; 23(R1):R89-98. PMC: 4170722. DOI: 10.1093/hmg/ddu328. View

3.
Pierce B, Burgess S . Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013; 178(7):1177-84. PMC: 3783091. DOI: 10.1093/aje/kwt084. View

4.
Bowden J, Davey Smith G, Burgess S . Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015; 44(2):512-25. PMC: 4469799. DOI: 10.1093/ije/dyv080. View

5.
Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View